Library / regulatory-reference
Kenya: Pharmacy and Poisons Board (PPB)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Pharmacy and Poisons Board is Kenya's national regulator for medicines, medical devices and the practice of pharmacy, a statutory body under the Ministry of Health with a mandate that combines product registration with professional oversight.
Kenya is East Africa's largest economy and a regional healthcare hub, and the board's registrations and practice standards anchor the region's pharmaceutical sector.
How products enter the market
Medicines require registration before marketing, with evaluation of quality, safety and efficacy, and retention and variation processes keeping registrations current. The board maintains an online register of registered products and licensed premises.
Medical devices and diagnostics come under its registration remit, and the board also licenses pharmacists, pharmacies and wholesale dealers, giving it a dual product-and-profession remit characteristic of pharmacy-board systems.
Regional and international role
The board is a leading East African regulator: it works through regional harmonization initiatives and has adopted reliance-informed pathways that credit assessments by trusted authorities for defined products.
Kenya's position as a regional distribution hub means its licensing and inspection standards influence supply chains across East Africa, and its pharmacovigilance center contributes actively to continental safety monitoring.
Using this profile
The board publishes registers, guidance and public notices in English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the Pharmacy and Poisons Board illustrates the combined product-and-profession regulator, registering medicines and devices while licensing the pharmacists and premises through which they reach patients.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.